• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Age is major factor for predicting survival in patients with acute respiratory failure on extracorporeal membrane oxygenation: a Korean multicenter study.年龄是预测接受体外膜肺氧合治疗的急性呼吸衰竭患者生存率的主要因素:一项韩国多中心研究。
J Thorac Dis. 2018 Mar;10(3):1406-1417. doi: 10.21037/jtd.2018.03.71.
2
[Predictive values of different critical scoring systems for mortality in patients with severe acute respiratory failure supported by extracorporeal membrane oxygenation].[不同危急评分系统对体外膜肺氧合支持下的严重急性呼吸衰竭患者死亡率的预测价值]
Zhonghua Jie He He Hu Xi Za Zhi. 2016 Sep;39(9):698-703. doi: 10.3760/cma.j.issn.1001-0939.2016.09.008.
3
Comparison of mortality prediction models in acute respiratory distress syndrome undergoing extracorporeal membrane oxygenation and development of a novel prediction score: the PREdiction of Survival on ECMO Therapy-Score (PRESET-Score).体外膜肺氧合治疗急性呼吸窘迫综合征患者的死亡率预测模型比较及新型预测评分的建立:体外膜肺氧合治疗存活预测评分(PRESET 评分)。
Crit Care. 2017 Dec 12;21(1):301. doi: 10.1186/s13054-017-1888-6.
4
Efficacy of outcome prediction of the respiratory ECMO survival prediction score and the predicting death for severe ARDS on VV-ECMO score for patients with acute respiratory distress syndrome on extracorporeal membrane oxygenation.体外膜肺氧合治疗的急性呼吸窘迫综合征患者中,呼吸体外膜肺氧合生存预测评分对预后预测的效能以及重度急性呼吸窘迫综合征患者在静脉-静脉体外膜肺氧合模式下预测死亡的评分。
Perfusion. 2023 Oct;38(7):1340-1348. doi: 10.1177/02676591221115267. Epub 2022 Jul 13.
5
Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score.体外膜肺氧合治疗严重急性呼吸衰竭患者的预后预测。呼吸体外膜肺氧合生存预测(RESP)评分。
Am J Respir Crit Care Med. 2014 Jun 1;189(11):1374-82. doi: 10.1164/rccm.201311-2023OC.
6
Respiratory ECMO Survival Prediction (RESP) Score for COVID-19 Patients Treated with ECMO.用于 COVID-19 患者 ECMO 治疗的呼吸 ECMO 生存预测(RESP)评分。
ASAIO J. 2022 Apr 1;68(4):486-491. doi: 10.1097/MAT.0000000000001640.
7
Outcomes in trauma patients undergoing veno-venous extracorporeal membrane oxygenation for acute respiratory distress syndrome.创伤患者行体外膜肺氧合治疗急性呼吸窘迫综合征的结局。
Perfusion. 2023 Jul;38(5):1037-1044. doi: 10.1177/02676591221093880. Epub 2022 Jun 9.
8
Performance of Multiple Risk Assessment Tools to Predict Mortality for Adult Respiratory Distress Syndrome with Extracorporeal Membrane Oxygenation Therapy: An External Validation Study Based on Chinese Single-center Data.多种风险评估工具预测接受体外膜肺氧合治疗的成人呼吸窘迫综合征死亡率的性能:基于中国单中心数据的外部验证研究
Chin Med J (Engl). 2016 Jul 20;129(14):1688-95. doi: 10.4103/0366-6999.185871.
9
Predicting Survival After Extracorporeal Membrane Oxygenation for ARDS: An External Validation of RESP and PRESERVE Scores.预测急性呼吸窘迫综合征体外膜肺氧合后的生存率:RESP和PRESERVE评分的外部验证
Respir Care. 2017 Jul;62(7):912-919. doi: 10.4187/respcare.05098. Epub 2017 May 23.
10
Anticoagulation and Transfusions Management in Veno-Venous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: Assessment of Factors Associated With Transfusion Requirements and Mortality.急性呼吸窘迫综合征行静脉-静脉体外膜肺氧合抗凝和输血管理:输血需求和死亡率相关因素评估。
J Intensive Care Med. 2019 Aug;34(8):630-639. doi: 10.1177/0885066617706339. Epub 2017 May 1.

引用本文的文献

1
Trends and management of acute respiratory failure in hospitalized patients: a multicenter retrospective study in South Korea.住院患者急性呼吸衰竭的趋势与管理:韩国的一项多中心回顾性研究
Acute Crit Care. 2025 May;40(2):171-185. doi: 10.4266/acc.004728. Epub 2025 May 28.
2
ECMO as a bridge to heart transplantation: Insights into stratification by heart failure etiology.体外膜肺氧合作为心脏移植的桥梁:对心力衰竭病因分层的见解。
JHLT Open. 2024 Apr 26;5:100097. doi: 10.1016/j.jhlto.2024.100097. eCollection 2024 Aug.
3
Predicting Healthcare-Associated Infection in Patients with Pneumonia via QuantiFERON-Monitoring.通过定量干扰素监测预测肺炎患者的医疗相关感染
Infect Drug Resist. 2025 Mar 12;18:1381-1391. doi: 10.2147/IDR.S499765. eCollection 2025.
4
Predictors of mortality in trauma patients with acute respiratory distress syndrome receiving extracorporeal membrane oxygenation.接受体外膜肺氧合治疗的创伤后急性呼吸窘迫综合征患者的死亡预测因素。
Surg Pract Sci. 2022 Mar 23;9:100071. doi: 10.1016/j.sipas.2022.100071. eCollection 2022 Jun.
5
Successful bilateral lung transplantation after prolonged ECMO support for aspiration pneumonia in a 79-year-old man.一名79岁男性因吸入性肺炎在接受长时间体外膜肺氧合(ECMO)支持后成功进行双侧肺移植。
Indian J Thorac Cardiovasc Surg. 2025 Feb;41(2):179-183. doi: 10.1007/s12055-024-01749-y. Epub 2024 May 29.
6
Supervised machine learning model to predict mortality in patients undergoing venovenous extracorporeal membrane oxygenation from a nationwide multicentre registry.基于全国多中心登记研究的机器学习模型预测行静脉-静脉体外膜肺氧合患者的死亡率。
BMJ Open Respir Res. 2023 Dec 28;10(1):e002025. doi: 10.1136/bmjresp-2023-002025.
7
Predictive models in extracorporeal membrane oxygenation (ECMO): a systematic review.体外膜肺氧合(ECMO)中的预测模型:系统评价。
Syst Rev. 2023 Mar 15;12(1):44. doi: 10.1186/s13643-023-02211-7.
8
Age is an important prognostic factor in COVID-19 patients treated with extracorporeal membrane oxygenation.年龄是接受体外膜肺氧合治疗的COVID-19患者的一个重要预后因素。
J Thorac Dis. 2022 Aug;14(8):3094-3097. doi: 10.21037/jtd-22-493.
9
Trend of extracorporeal membrane oxygenation support in patients with acute respiratory distress syndrome in South Korea.韩国急性呼吸窘迫综合征患者体外膜肺氧合支持的趋势。
Sci Rep. 2022 Mar 28;12(1):5225. doi: 10.1038/s41598-022-09230-9.
10
Neutrophil-lymphoycyte-ratio, platelet-lymphocyte-ratio and procalcitonin for early assessment of prognosis in patients undergoing VA-ECMO.中性粒细胞-淋巴细胞比值、血小板-淋巴细胞比值和降钙素原在 VA-ECMO 患者预后早期评估中的作用。
Sci Rep. 2022 Jan 11;12(1):542. doi: 10.1038/s41598-021-04519-7.

本文引用的文献

1
Cannulation techniques for extracorporeal life support.体外生命支持的插管技术。
Ann Transl Med. 2017 Feb;5(4):70. doi: 10.21037/atm.2016.11.47.
2
The status of intensive care medicine research and a future agenda for very old patients in the ICU.重症监护医学研究的现状及 ICU 中非常老年患者的未来议程。
Intensive Care Med. 2017 Sep;43(9):1319-1328. doi: 10.1007/s00134-017-4718-z. Epub 2017 Feb 25.
3
Outcomes and survival prediction models for severe adult acute respiratory distress syndrome treated with extracorporeal membrane oxygenation.接受体外膜肺氧合治疗的重度成人急性呼吸窘迫综合征的预后及生存预测模型
Crit Care. 2016 Dec 5;20(1):392. doi: 10.1186/s13054-016-1568-y.
4
Validity of Outcome Prediction Scoring Systems in Korean Patients with Severe Adult Respiratory Distress Syndrome Receiving Extracorporeal Membrane Oxygenation Therapy.接受体外膜肺氧合治疗的韩国重症成人呼吸窘迫综合征患者结局预测评分系统的有效性
J Korean Med Sci. 2016 Jun;31(6):932-8. doi: 10.3346/jkms.2016.31.6.932. Epub 2016 Apr 21.
5
Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.全球 50 个国家重症监护病房急性呼吸窘迫综合征患者的流行病学、治疗模式和死亡率。
JAMA. 2016 Feb 23;315(8):788-800. doi: 10.1001/jama.2016.0291.
6
External validation of scores proposed for estimation of survival probability of patients with severe adult respiratory distress syndrome undergoing extracorporeal membrane oxygenation therapy: a retrospective study.用于评估接受体外膜肺氧合治疗的重症成人呼吸窘迫综合征患者生存概率的评分系统的外部验证:一项回顾性研究
Crit Care. 2015 Apr 7;19:142. doi: 10.1186/s13054-015-0875-z.
7
Extracorporeal membrane oxygenation for respiratory failure in the elderly: a review of the Extracorporeal Life Support Organization registry.老年呼吸衰竭的体外膜肺氧合:体外生命支持组织登记处综述
ASAIO J. 2014 Jul-Aug;60(4):385-90. doi: 10.1097/MAT.0000000000000090.
8
Prediction of mortality in adult patients with severe acute lung failure receiving veno-venous extracorporeal membrane oxygenation: a prospective observational study.接受静脉-静脉体外膜肺氧合治疗的严重急性肺衰竭成年患者死亡率的预测:一项前瞻性观察研究。
Crit Care. 2014 Apr 9;18(2):R67. doi: 10.1186/cc13824.
9
Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score.体外膜肺氧合治疗严重急性呼吸衰竭患者的预后预测。呼吸体外膜肺氧合生存预测(RESP)评分。
Am J Respir Crit Care Med. 2014 Jun 1;189(11):1374-82. doi: 10.1164/rccm.201311-2023OC.
10
Outcome of acute respiratory distress syndrome patients treated with extracorporeal membrane oxygenation and brought to a referral center.接受体外膜肺氧合治疗并转诊至某转诊中心的急性呼吸窘迫综合征患者的治疗结果
Intensive Care Med. 2014 Jan;40(1):74-83. doi: 10.1007/s00134-013-3135-1. Epub 2013 Oct 30.

年龄是预测接受体外膜肺氧合治疗的急性呼吸衰竭患者生存率的主要因素:一项韩国多中心研究。

Age is major factor for predicting survival in patients with acute respiratory failure on extracorporeal membrane oxygenation: a Korean multicenter study.

作者信息

Baek Moon Seong, Chung Chi Ryang, Kim Hwa Jung, Cho Woo Hyun, Cho Young-Jae, Park Sunghoon, Park Seung Yong, Kang Byung Ju, Kim Jung-Hyun, Park So Hee, Oh Jin Young, Sim Yun Su, Hong Sang-Bum

机构信息

Department of Pulmonary and Critical Care Medicine, Asan Medical Center, Seoul, Republic of Korea.

Department of Critical Care Medicine, Samsung Medical Center, Seoul, Republic of Korea.

出版信息

J Thorac Dis. 2018 Mar;10(3):1406-1417. doi: 10.21037/jtd.2018.03.71.

DOI:10.21037/jtd.2018.03.71
PMID:29707290
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC5906318/
Abstract

BACKGROUND

The proportion of elderly patients in the intensive care unit population is increasing. Although the Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score is widely used for survival prediction of extracorporeal membrane oxygenation (ECMO) patients, it is questionable whether the RESP score is applicable to older patients. The aim of this study was to investigate the applicability of the RESP score in Korean cohort.

METHODS

Data were retrospectively analyzed from 209 acute respiratory failure (ARF) patients treated with ECMO from 2014 to 2015 at 11 hospitals. A comparison of outcome prediction models was conducted and multivariate logistic regression analysis was performed to identify independent risk factors for hospital mortality.

RESULTS

In all patients, the median age was 58 (IQR, 45-65) years. Overall survival at hospital discharge was 45.9%, and veno-venous ECMO was used in 82.3% of patients. Patients older than 65 years treated with ECMO support were 51 with 31.4% of hospital survival. The PRedicting dEath for SEvere ARDS on VV-ECMO (PRESERVE) and RESP scores significantly predicted mortality in patients, with areas under the curve (AUCs) of 0.63 [95% confidence interval (CI), 0.54-0.72] and 0.66 (95% CI, 0.58-0.73), respectively. In multivariate logistic regression analysis, age is independent risk factor for hospital mortality [odds ratio 1.044 (95% CI, 1.020-1.068), P<0.001] with AUC of 0.67 (95% CI, 0.59-0.74). The RESP score was modified using reclassified age and the modified RESP score obtained AUC of 0.71 (95% CI, 0.63-0.78).

CONCLUSIONS

The RESP score is significant model for predicting outcomes in a Korean ECMO population. Elderly patients had higher mortality, and age alone showed similar discrimination ability for prediction of mortality compared to the RESP score.

摘要

背景

重症监护病房中老年患者的比例正在增加。尽管呼吸体外膜肺氧合生存预测(RESP)评分被广泛用于体外膜肺氧合(ECMO)患者的生存预测,但RESP评分是否适用于老年患者仍存在疑问。本研究的目的是调查RESP评分在韩国队列中的适用性。

方法

对2014年至2015年期间11家医院接受ECMO治疗的209例急性呼吸衰竭(ARF)患者的数据进行回顾性分析。进行了结局预测模型的比较,并进行多因素逻辑回归分析以确定医院死亡率的独立危险因素。

结果

所有患者的中位年龄为58岁(四分位间距,45 - 65岁)。出院时的总体生存率为45.9%,82.3%的患者使用了静脉 - 静脉ECMO。接受ECMO支持的65岁以上患者有51例,医院生存率为31.4%。预测VV - ECMO上严重ARDS死亡(PRESERVE)评分和RESP评分显著预测了患者的死亡率,曲线下面积(AUC)分别为0.63 [95%置信区间(CI),0.54 - 0.72]和0.66(95% CI,0.58 - 0.73)。在多因素逻辑回归分析中,年龄是医院死亡率的独立危险因素[比值比1.044(95% CI,1.020 - 1.068),P < 0.001],AUC为0.67(95% CI,0.59 - 0.74)。使用重新分类的年龄对RESP评分进行了修正,修正后的RESP评分AUC为0.71(95% CI,0.63 - 0.78)。

结论

RESP评分是预测韩国ECMO人群结局的重要模型。老年患者死亡率较高,单独年龄与RESP评分相比,在预测死亡率方面显示出相似的辨别能力。